Zárate MF, Cervantes BR, Mata RN, Zárate MF, Montijo BE, Bacarreza ND, Ramírez MJA

Language: Spanish
References: 22
Page: 114-117
PDF size: 139.18 Kb.

ABSTRACT

Hepatitis B and C have been a worldwide public health issue, because of their high prevalence. Due to the great difficulties that sometimes involves diagnosis and the great controversy surrounding its treatment, we carried out an extensive review of the literature regarding the diagnosis and treatment in children.

REFERENCES

1. Lok AS, Heathcote EJ, Hoofnagle JH. Management of hepatitis B 2000. Summary of a Workshop. Gastroenterology 2001;120:1828-53.

2. Tanaka J. Hepatitis B epidemiology in Latin America. Vaccine 2000;18(Suppl 1):S17-S19.

3. Alter MJ. Epidemiology of hepatitis C. Hepatology 1997;26:S62-S65.

4. Chaudary R, Mo T. Antibody to hepatitis C in risk groups in Canada. Can J Infect Dis 1992;3:27-9.

5. Wong JB, McMillan GM, Mc Hutchinson JG, Poynard T. Estimating future of hepatitis C morbidity, mortality, and costs in the United States. Am J Public Health 2000;90:1562-69.

6. Jonas M. Children with hepatitis C. Hepatology 2003;36(Suppl):S173-S178.

7. Ramirez-Mayans J, Cervantes-Bustamante R, Zárate-Mondragón F, Mata-Rivera N, Tello-Bernal M, Navarrete-Delagdillo N, Sosa de Martínez C. Hepatitis C virus antibodies in a Mexican populations. Ped Inf Dis J 1998;17(2):169-70.

8. Wong JB, Mc Millan GM, McHutchinson J, Poynard T. Estimating future of hepatitis C morbidity, mortality, and costs in the United States. Am J Public Health 2000;90:1562-9.

9. Elisofon SA, Jonas MM. Hepatitis B y C in children: Current treatment and future strategies. Clin Liv Dis 2006;10:133-48.

10. Shneider BL, González-Peralta R, Roberts EA. Controversies in the management of pediatric liver disease: Hepatitis B, C and NAFLD: summary of a single topic conference. Hepatology 2006; 44(5):1344-54.

11. Lok ASF, McMahon BJ. Chronic hepatitis B. Hepatology 2007;45(2):507-39.

12. Lok ASF, McMahon BJ. Chronic hepatitis B. Hepatology 2001;34(6):1125-41.

13. Gjorup IE, Skinhoj P. New aspects on the natural history of chronic hepatitis B infection: implication for therapy. Scand J Infect Dis 2003;35:808-13.

14. Hoofnagle JH, Doo E, Liang TJ, Fleischer R, Lok ASF. Management of hepatitis B: summary of a clinical research workshop. Hepatology 2007;45(4):1056-75.

15. Shah U, Memeno I, Cheema HA, Ali S, Thobani S, Mirza R. Recommendations for the treatment of chronic hepatitis B infection in children. J Pak Med Assoc 2007;57(4):204-7.

16. Lau G. Does treatment with interferon-based therapy improve the natural history of chronic hepatitis B infection? J Hepatology 2007;46:6-8.

17. Raimondo G, Pollicino T, Cacciola I, Squadrito G. Occult hepatitis B virus infection. J Hepatology 2007;46:160-70.

18. Sherman M, Bain V, Villeneuve JP, Myers RP, Cooper C, Martin S, Lowe C. Management of viral hepatitis. A Canadian Consensus Conference, 2003-2004.

19. Scottish Intercollegiate Guidelines Network. Management of hepatitis C. A national clinical guideline, 2006. Internet. En línea, disponible en: www.sign.ac.uk, consultado en 2007.

20. Leroy V, Hilleret MN, Sturn N, Trocme C, Renversez JC, Faure P, Morel F, Zarski JP. Prospective comparison of six non-invasive scores for the diagnosis of liver fibrosis in chronic hepatitis C. J Hepatology 2007;46:775-82.

21. Burroughs AK, Cholongitas E. Non–invasive tests for liver fibrosis: encouraging or discouraging results? J Hepatology 2007;46:751-55.

22. Goodman ZD, Becker RL, Pockros PJ, Afdhal NZ. Progression of fibrosis in advanced chronic hepatitis C: Evaluation by morphometric image analysis. Hepatology 2007;45(4):886-94.